A fully automated solid-phase radioimmunoassay for triiodothyronine.

Area of Science:

• Endocrinology
• Immunoassay Development
• Clinical Chemistry

Background:

• Triiodothyronine (T3) is a crucial thyroid hormone regulating metabolism.
• Accurate T3 measurement is essential for diagnosing thyroid disorders.
• Existing radioimmunoassay methods can be labor-intensive and time-consuming.

Purpose of the Study:

• To develop and validate a novel solid-phase radioimmunoassay for triiodothyronine (T3).
• To adapt the assay for full automation using the Micromedic Systems Concept 4 instrument.
• To assess the assay's analytical performance and compare it with existing methods.

Main Methods:

• Solid-phase radioimmunoassay utilizing antibody-coated polypropylene tubes.
• Antisera raised against triiodothyropropionic acid/bovine serum albumin.
• Assay validation including analytical recovery, intra-assay and inter-assay variability, and correlation studies.
• Utilized the Micromedic Systems Concept 4 Automatic Radioassay instrument for automation.

Main Results:

• Quantitative recovery of exogenous triiodothyronine from human sera.
• Low intra-assay (4-5%) and inter-assay (6-9%) coefficients of variation.
• High correlation coefficients (r=0.95, 0.84, 0.91) with commercial laboratory results.
• Assay sensitivity of 0.5 microng/liter.

Conclusions:

• The developed solid-phase radioimmunoassay for T3 is accurate, precise, and sensitive.
• The assay is suitable for both manual and fully automated performance on the Concept 4 instrument.
• This method offers a reliable tool for T3 determination in clinical settings.